Literature DB >> 33484825

Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury.

Maija Dambrova1, Coert J Zuurbier2, Vilmante Borutaite3, Edgars Liepinsh4, Marina Makrecka-Kuka4.   

Abstract

The heart is the most metabolically flexible organ with respect to the use of substrates available in different states of energy metabolism. Cardiac mitochondria sense substrate availability and ensure the efficiency of oxidative phosphorylation and heart function. Mitochondria also play a critical role in cardiac ischemia/reperfusion injury, during which they are directly involved in ROS-producing pathophysiological mechanisms. This review explores the mechanisms of ROS production within the energy metabolism pathways and focuses on the impact of different substrates. We describe the main metabolites accumulating during ischemia in the glucose, fatty acid, and Krebs cycle pathways. Hyperglycemia, often present in the acute stress condition of ischemia/reperfusion, increases cytosolic ROS concentrations through the activation of NADPH oxidase 2 and increases mitochondrial ROS through the metabolic overloading and decreased binding of hexokinase II to mitochondria. Fatty acid-linked ROS production is related to the increased fatty acid flux and corresponding accumulation of long-chain acylcarnitines. Succinate that accumulates during anoxia/ischemia is suggested to be the main source of ROS, and the role of itaconate as an inhibitor of succinate dehydrogenase is emerging. We discuss the strategies to modulate and counteract the accumulation of substrates that yield ROS and the therapeutic implications of this concept.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac injury; Energy metabolism; Ischemia/reperfusion; Long-chain acylcarnitines; Mitochondria; Reactive oxygen species; Succinate

Mesh:

Substances:

Year:  2021        PMID: 33484825     DOI: 10.1016/j.freeradbiomed.2021.01.036

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  12 in total

1.  Serum Metabolomics Reveals Distinct Profiles during Ischemia and Reperfusion in a Porcine Model of Myocardial Ischemia-Reperfusion.

Authors:  Eric Goetzman; Zhenwei Gong; Dhivyaa Rajasundaram; Ishan Muzumdar; Traci Goodchild; David Lefer; Radhika Muzumdar
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

2.  Even chained acylcarnitines predict long-term cardiovascular prognosis in patients with chest pain and non-obstructive coronary artery disease.

Authors:  Silje Kjellevold Storesund; Iman Karaji; Elin Strand; Asbjørn Svardal; Mai Tone Lønnebakken; Rolf Kristian Berge; Gard Frodahl Tveitevåg Svingen; Ottar Kjell Nygård; Eva Ringdal Pedersen
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2022-05-17

Review 3.  Antioxidant Therapy in Cancer: Rationale and Progress.

Authors:  Maochao Luo; Li Zhou; Zhao Huang; Bowen Li; Edouard C Nice; Jia Xu; Canhua Huang
Journal:  Antioxidants (Basel)       Date:  2022-06-08

4.  Postmortem Metabolomics Reveal Acylcarnitines as Potential Biomarkers for Fatal Oxycodone-Related Intoxication.

Authors:  Albert Elmsjö; Carl Söderberg; Gerd Jakobsson; Henrik Green; Robert Kronstrand
Journal:  Metabolites       Date:  2022-01-25

Review 5.  Mitochondrial Damage in Myocardial Ischemia/Reperfusion Injury and Application of Natural Plant Products.

Authors:  Xin Su; Mingyang Zhou; Yingjian Li; Na An; Fan Yang; Guoxia Zhang; Lianjiang Xu; Hengwen Chen; Hongjin Wu; Yanwei Xing
Journal:  Oxid Med Cell Longev       Date:  2022-05-16       Impact factor: 7.310

6.  Metabolic Impairment in Coronary Artery Disease: Elevated Serum Acylcarnitines Under the Spotlights.

Authors:  Joséphine Gander; Justin Carrard; Hector Gallart-Ayala; Rébecca Borreggine; Tony Teav; Denis Infanger; Flora Colledge; Lukas Streese; Jonathan Wagner; Christopher Klenk; Gilles Nève; Raphael Knaier; Henner Hanssen; Arno Schmidt-Trucksäss; Julijana Ivanisevic
Journal:  Front Cardiovasc Med       Date:  2021-12-16

7.  Protective Effects of Meldonium in Experimental Models of Cardiovascular Complications with a Potential Application in COVID-19.

Authors:  Reinis Vilskersts; Dana Kigitovica; Stanislava Korzh; Melita Videja; Karlis Vilks; Helena Cirule; Andris Skride; Marina Makrecka-Kuka; Edgars Liepinsh; Maija Dambrova
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 8.  Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury.

Authors:  Naranjan S Dhalla; Anureet K Shah; Adriana Adameova; Monika Bartekova
Journal:  Biomedicines       Date:  2022-06-22

Review 9.  Mitochondrial Metabolism in Myocardial Remodeling and Mechanical Unloading: Implications for Ischemic Heart Disease.

Authors:  Min Jiang; Xiaoye Xie; Feng Cao; Yabin Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-09

10.  Inhibition of Fatty Acid Metabolism Increases EPA and DHA Levels and Protects against Myocardial Ischaemia-Reperfusion Injury in Zucker Rats.

Authors:  Janis Kuka; Marina Makrecka-Kuka; Karlis Vilks; Stanislava Korzh; Helena Cirule; Eduards Sevostjanovs; Solveiga Grinberga; Maija Dambrova; Edgars Liepinsh
Journal:  Oxid Med Cell Longev       Date:  2021-07-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.